176:
211:
companies in the period from 2005 to 2009, some of them in the CNB spin-off incubator. The CNB is a member of ASEBIO, the largest
Spanish biotechnological business association, and maintains regular contacts with other members in search of common matters of interest; these include a number of joint grants for which companies and the CNB have applied to different government agencies. Of these, 12 projects were granted duting 2005-2009 in programs such as PETRI and PROFIT (amounting to €1.87m).
200:
38:
188:
diseases, construction of vaccines for humans and farm animals, development of tools to improve plant productivity and resistance to environmental stress, development of new processes for environmental recovery based on microorganisms, production of antibiotics and hydrolytic enzymes, and discovery of immunomodulatory compounds.
187:
Specific projects focus on structural biology of large macromolecules, genomics and functional proteomics, development of biocomputing tools, control of cell growth and cancer, mechanisms of aging and apoptosis, development of animal models for chronic autoimmune diseases, infectious and cancer-like
210:
During the same period, 87 patents were applied for, of which 33 were for new inventions, 33 were applications for entry into the international PCT phase, and 21 mainly for
European and US applications. Thirteen of these patents have been licensed. CNB scientists established five biotechnology
183:
The CNB is a multidisciplinary research centre that concentrates on the areas of structural biology, molecular biology, virology, microbiology, plant biology, immunology and oncology, and systems and synthetic biology. Research is used to generate useful applications.
219:
It is one of the largest
Spanish research institutes, with a total staff of 676 as of December 2011, of which 381 were scientific staff (65 PIs, 10 research associates, 113 PhD students and 198 postdoctoral scientists), and 236 technical and administrative staff.
146:
The stated mission of the CNB is the generation of scientific knowledge and its application to solving human and animal health issues, environmental, and agricultural challenges, whilst collaborating with industries and ensuring the transfer of technology.
375:
191:
A Program on
Systems and Synthetic Biology provides computational and materials tools for modelling complex biological phenomena and reprogramming them in a biotechnological direction.
150:
The CNB trains personnel, offers biotechnology-oriented counselling to companies and public institutions, and publishes its scientific activity in specialized journals and press media.
17:
380:
326:"Orden de 24 de enero de 1985 por la que se crea en el seno del Consejo Superior de Investigaciones CientĂficas, el Centro Nacional de IngenierĂa GenĂ©tica y BiotecnologĂa"
138:
The CNB was founded in 1992 to promote research in advanced biotechnology and molecular biology, and to act as a link between basic research and industrial applications.
402:
303:
101:
179:
A diagram showing the structure of HIV virus. The group of
Mariano Esteban have generated a vaccine which already passed the phase I clinical trials
273:
207:
As a biotechnology center the CNB over the 2005-2009 period signed 225 research contracts with companies around the world (amounting to €37.4m).
293:
397:
132:
203:
The group of Salomé Prat generated transgenic potatoes which would be able to grow in sub-Saharan Africa.
283:
346:
157:
Focus the effort in life sciences research towards a society and an economy based on knowledge
325:
8:
381:
La investigaciĂłn sobre
Enfermedades Raras en el Centro Nacional de BiotecnologĂa del CSIC
166:
Stimulate private companies towards research and development for biological problems
163:
Offer services in new technologies to the academic community and private companies
160:
Use this knowledge as a tool to be applied to health, agriculture and environment
391:
376:
La vacuna contra el VIH generada en el CNB logra una respuesta inmune del 90%
347:"El Centro Nacional de BiotecnologĂa echa a andar con un director cesado"
175:
199:
153:
The most relevant stated missions of the CNB are the following:
72:
61:
37:
370:
135:(CSIC), the largest public research institution in Spain.
115:
389:
71:Calle Darwin nÂş 3, Campus de Cantoblanco. 28049
243:and a Program on Systems and Synthetic Biology
18:Spanish National Center for Biotechnology (CNB)
403:Research institutes in the Community of Madrid
27:Part of the Spanish National Research Council
223:The CNB is divided into five departments:
31:Spanish National Center for Biotechnology
198:
174:
14:
390:
194:
230:Molecular and Cell Biology Department
227:Macromolecular Structure Department
24:
239:Immunology and Oncology Department
233:Microbial Biotechnology Department
25:
414:
364:
133:Spanish National Research Council
125:National Center for Biotechnology
36:
214:
339:
318:
13:
1:
311:
304:JosĂ© MarĂa Valpuesta Moralejo
102:JosĂ© MarĂa Valpuesta Moralejo
398:1985 establishments in Spain
246:
7:
170:
10:
419:
141:
294:José Ramón Naranjo Orovio
236:Plant Genetics Department
111:
94:
86:
78:
67:
57:
49:
44:
35:
349:. Elpais.com. 1992-07-10
204:
180:
116:http://www.cnb.csic.es
82:676 (as December 2011)
274:José López Carrascosa
202:
178:
328:. Boe.es. 1985-01-24
131:) forms part of the
195:Technology transfer
32:
265:Michael Parkhouse
205:
181:
30:
309:
308:
121:
120:
16:(Redirected from
410:
358:
357:
355:
354:
343:
337:
336:
334:
333:
322:
251:
250:
95:Agency executive
53:January 24, 1985
40:
33:
29:
21:
418:
417:
413:
412:
411:
409:
408:
407:
388:
387:
367:
362:
361:
352:
350:
345:
344:
340:
331:
329:
324:
323:
319:
314:
284:Mariano Esteban
249:
217:
197:
173:
144:
107:
45:Agency overview
28:
23:
22:
15:
12:
11:
5:
416:
406:
405:
400:
384:
383:
378:
373:
366:
365:External links
363:
360:
359:
338:
316:
315:
313:
310:
307:
306:
301:
297:
296:
291:
287:
286:
281:
277:
276:
271:
267:
266:
263:
259:
258:
255:
248:
245:
241:
240:
237:
234:
231:
228:
216:
213:
196:
193:
172:
169:
168:
167:
164:
161:
158:
143:
140:
119:
118:
113:
109:
108:
106:
105:
98:
96:
92:
91:
88:
84:
83:
80:
76:
75:
69:
65:
64:
59:
55:
54:
51:
47:
46:
42:
41:
26:
9:
6:
4:
3:
2:
415:
404:
401:
399:
396:
395:
393:
386:
382:
379:
377:
374:
372:
369:
368:
348:
342:
327:
321:
317:
305:
302:
299:
298:
295:
292:
289:
288:
285:
282:
279:
278:
275:
272:
269:
268:
264:
261:
260:
256:
253:
252:
244:
238:
235:
232:
229:
226:
225:
224:
221:
212:
208:
201:
192:
189:
185:
177:
165:
162:
159:
156:
155:
154:
151:
148:
139:
136:
134:
130:
126:
117:
114:
110:
103:
100:
99:
97:
93:
89:
87:Annual budget
85:
81:
77:
74:
70:
66:
63:
60:
56:
52:
48:
43:
39:
34:
19:
385:
351:. Retrieved
341:
330:. Retrieved
320:
242:
222:
218:
215:Organization
209:
206:
190:
186:
182:
152:
149:
145:
137:
128:
124:
122:
90:24 million €
68:Headquarters
58:Jurisdiction
371:Web del CNB
290:2003 - 2007
280:1992 - 2003
270:1990 - 1992
262:1987 - 1990
392:Categories
353:2014-06-02
332:2014-06-02
312:References
300:Since 2007
104:, Director
257:Director
247:Directors
79:Employees
171:Research
142:Mission
112:Website
254:Years
73:Madrid
50:Formed
62:Spain
123:The
129:CNB
394::
356:.
335:.
127:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
